Tag Archives: PANTHERx

Specialty Pharmacy News Roundup: August 2024

The latest specialty pharmacy news and insights. Stay up to date on industry and company activities with the industry-leading Specialty Pharmacy Database and custom research projects

Orsini and PANTHERx Selected as Limited Distribution Pharmacies for Gilead Science’s Livdelzi

Orsini and PANTHERx Selected as Limited Distribution Pharmacies for Gilead Science’s Livdelzi for the treatment of primary biliary cholangitis (PBC)

PANTHERx Selected by UCB as Exclusive Specialty Pharmacy for ZILBRYSQ

Zilbrysq is available through the specialty pharmacy PANTHERx Rare Pharmacy and through a Risk Evaluation and Mitigation Strategy (REMS) program because of the risk of serious meningococcal infections.

Centene Selects Express Scripts to Provide PBM Benefits in 2024

Centene recently announced that it reached its pharmacy platform migration milestones and is engaged in strategic discussions with potential PBM partners about how to drive additional quality and value in delivering pharmacy benefits to its members.

PANTHERx Rare Selected by Aadi Bioscience as Exclusive Distributor for FYARRO™

PANTHERx Rare announced that it has been selected by Aadi Bioscience (Aadi) as the exclusive U.S. pharmacy distribution partner for new drug FYARRO™ (sirolimus protein-bound particles for injectable suspension) (albumin-bound)

PANTHERx Rare selected by Xeris Pharmaceuticals as Exclusive Distributor of Recorlev

PANTHERx Rare was recently selected by Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc., as the exclusive U.S. pharmacy distribution partner for a new FDA-approved medication, Recorlev® (levoketoconazole).

PANTHERx and Amber Specialty Pharmacy Selected by ChemoCentryx to Dispense Tavneos

ChemoCentryx selected only Amber Specialty Pharmacy and PANTHERx as its limited distribution network for Tavenos

Centene’s Restructuring Initiative Focuses on Behavioral Health and Pharmacy Growth

Centene’s recent acquisition of PANTHERx will play a major role in the company’s specialty pharmacy growth